LLY

Lilly(Eli) & Co

Oct 13 • 04:00PM ET

819.40

-14.09 -1.69 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: NVO JNJ ABBV MRK AZN AMGN PFE SNY BMY GSK

| Held by: VTI VOO IVV SPY VUG XLV VIG IWF QUAL VHT

Index	S&P 500	P/E	54.33	EPS (ttm)	15.08	Insider Own	10.22%	Shs Outstand	946.83M	Perf Week	-3.04%
Market Cap	775.53B	Forward P/E	27.13	EPS next Y	30.20	Insider Trans	-1.50%	Shs Float	849.82M	Perf Month	8.47%
Enterprise Value	811.96B	PEG	1.31	EPS next Q	6.22	Inst Own	73.38%	Short Float	0.90%	Perf Quarter	6.17%
Income	13.80B	P/S	14.56	EPS this Y	74.94%	Inst Trans	-0.55%	Short Ratio	1.66	Perf Half Y	11.88%
Sales	53.26B	P/B	42.46	EPS next Y	32.89%	ROA	15.97%	Short Interest	7.69M	Perf YTD	6.14%
Book/sh	19.30	P/C	218.70	EPS next 5Y	41.44%	ROE	86.70%	52W High	937.00 -12.55%	Perf Year	-10.91%
Cash/sh	3.75	P/FCF	158.76	EPS past 3/5Y	24.14% 18.77%	ROIC	26.31%	52W Low	623.78 31.36%	Perf 3Y	146.10%
Dividend Est.	5.87 (0.72%)	EV/EBITDA	33.37	Sales past 3/5Y	16.73% 15.08%	Gross Margin	82.64%	Volatility	2.16% 2.78%	Perf 5Y	468.51%
Dividend TTM	5.80 (0.71%)	EV/Sales	15.25	EPS Y/Y TTM	88.21%	Oper. Margin	42.13%	ATR (14)	21.65	Perf 10Y	846.52%
Dividend Ex-Date	Aug 15, 2025	Quick Ratio	1.00	Sales Y/Y TTM	36.83%	Profit Margin	25.91%	RSI (14)	59.64	Recom	1.58
Dividend Gr. 3/5Y	15.21% 15.05%	Current Ratio	1.28	EPS Q/Q	91.71%	SMA20	4.12%	Beta	0.41	Target Price	916.54
Payout	44.39%	Debt/Eq	2.18	Sales Q/Q	37.64%	SMA50	10.09%	Rel Volume	0.47	Prev Close	833.49
Employees	47000	LT Debt/Eq	1.87	Earnings	Oct 30 BMO	SMA200	4.26%	Avg Volume	4.64M	Price	819.40
IPO	Jul 09, 1970	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.70% 5.80%	Trades		Volume	2,167,468	Change	-1.69%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-17-25	Downgrade	Berenberg	Buy → Hold	$830
Aug-27-25	Upgrade	HSBC Securities	Reduce → Hold	$700
Aug-18-25	Downgrade	Daiwa Securities	Outperform → Neutral	$700
Aug-07-25	Downgrade	Leerink Partners	Outperform → Market Perform	$715
Jun-05-25	Downgrade	Erste Group	Buy → Hold
Apr-28-25	Downgrade	HSBC Securities	Buy → Reduce	$1150 → $700
Apr-22-25	Initiated	Cantor Fitzgerald	Overweight	$975
Dec-10-24	Resumed	BofA Securities	Buy	$997
Nov-15-24	Initiated	Wolfe Research	Outperform	$1000
Oct-17-24	Initiated	Bernstein	Outperform	$1100
Sep-13-24	Resumed	Citigroup	Buy	$1060
Aug-12-24	Upgrade	Deutsche Bank	Hold → Buy	$1025
Feb-21-24	Downgrade	DZ Bank	Buy → Hold	$820
Feb-16-24	Reiterated	Morgan Stanley	Overweight	$805 → $950
Dec-21-23	Downgrade	Daiwa Securities	Buy → Outperform	$660 → $610
Nov-09-23	Initiated	Deutsche Bank	Hold	$535
Oct-20-23	Resumed	UBS	Buy	$612 → $710
Aug-09-23	Upgrade	Jefferies	Hold → Buy	$408 → $615
Jul-26-23	Reiterated	Citigroup	Buy	$360 → $525
Jul-14-23	Initiated	HSBC Securities	Buy	$560

Show Previous Ratings

Oct-13-25 04:15PM	Top Stock Reports for Apple, Eli Lilly & Visa (Zacks)
01:40PM	AZN Strikes Drug Pricing Deal With Trump, Gets 3-Year Tariff Reprieve (Zacks)
10:57AM	New US biotech hubs showing potential amid onshoring request (Pharmaceutical Technology)
09:28AM	Eli Lilly Omvoh Demonstrates Sustained Long-Term Benefits in Ulcerative Colitis Up to Four Years (Insider Monkey)
06:45AM	Lilly to present new clinical data for Verzenio (abemaciclib) and multiple novel pipeline programs at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting (PR Newswire)
06:10AM	Loading…
06:10AM	Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? (Motley Fool)
Oct-11-25 07:00AM	MarketBeat Week in Review - 10/06 - 10/10 (MarketBeat)
Oct-10-25 09:54AM	Can Novo Nordisk's Aggressive Deal-Making Offset Semaglutide Reliance? (Zacks)
08:50AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises (Zacks)
06:45AM	2 Pharmaceutical Stocks That Look Like No-Brainer Buys Right Now (Motley Fool)
06:30AM	Novo Nordisk Seeks to Expand Liver Disease Treatments in $5.2B Deal for Bay Area Biotech (The Daily Upside)
05:32AM	Pharma R&D set to endure despite rising MFN costs (Clinical Trials Arena)
Oct-09-25 05:45PM	Eli Lilly (LLY) Gains As Market Dips: What You Should Know (Zacks)
03:26PM	A Major Eli Lilly Shareholder Has Sold Stock Nearly Every Day in October. Here's Who It Is. (Barrons.com)
11:17AM	Novo Nordisk Is Buying Akero Therapeutics. Its More Good News for Biotech Stocks. (Barrons.com)
11:00AM	Loading…
11:00AM	Is Novo Nordisk Stock a Sell Despite its 10% Price Rally in a Month? (Zacks)
10:14AM	AbbVie vs. Eli Lilly: Which Large Drugmaker Has the Edge in 2025? (Zacks)
10:08AM	Novo Nordisk buys MASH specialist Akero for up to $5.2bn (Pharmaceutical Technology)
08:03AM	5 Healthcare Plays Powering the Sector's Big Comeback (MarketBeat)
07:30AM	Watch Out Eli Lilly, This Pharma Giant Is Gunning to Be a Top Player in the Obesity Market (Motley Fool)
Oct-08-25 04:47PM	Hims Stock, Up 138%: IBD Stock Of The Day Makes Another Breakout Run (Investor's Business Daily)
03:55PM	Tariff turbulence deepens uncertainty across US supply chains (FreightWaves)
10:56AM	Can BMYs Neuroscience Portfolio Help to Diversify Its Business? (Zacks)
10:43AM	Ex-FDA chief Peter Marks joins Eli Lillys infectious disease unit (Pharmaceutical Technology)
10:02AM	Guggenheim Reaffirms Its Buy Rating on Eli Lilly & Company (LLY) with Price Target of $875 (Insider Monkey)
06:31AM	These 2 AI Stocks Could Surpass Oracle in Market Cap by 2030 (Motley Fool)
Oct-07-25 06:01PM	Top Stock Picks for Week of October 6, 2025 (Zacks)
05:04PM	Former Top FDA Official, Forced Out by Kennedy, Lands at Eli Lilly (Barrons.com)
12:20PM	Peter Marks, former top FDA vaccine official, joins Eli Lilly (BioPharma Dive)
09:33AM	Where Will LLY Be in 5 Years? (Motley Fool)
09:00AM	Loading…
09:00AM	Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
06:45AM	Lilly's Omvoh (mirikizumab-mrkz) is the first and only IL-23p19 antagonist to show four years of sustained, corticosteroid-free comprehensive patient outcomes in ulcerative colitis (PR Newswire)
06:05AM	Eli Lilly to invest more than $1B in India, Reuters reports (TipRanks)
06:00AM	Hiltzik: There's much less than meets the eye in Trump's 'historic' drug price deal with Pfizer (LA Times)
05:53AM	Novo Nordisk cuts hit production line jobs at key US plant, posts show (Reuters Videos)
04:50AM	Eli Lilly plans major $1bn expansion in Telangana, India (Investment Monitor)
Oct-06-25 07:34PM	Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal (MarketBeat)
05:21PM	Eli Lilly to Invest Over $1 Billion in India to Expand Manufacturing Network (GuruFocus.com)
02:57PM	Eli Lilly's $1 Billion India Gamble Signals Pharma's Next Global Power Shift (GuruFocus.com)
02:21PM	Trump's Drug Price Cuts: Boom or Bust for These 3 Pharma Giants (MarketBeat)
01:57PM	Eli Lilly Stock Rises 16% in a Week: Here's What You Should Know (Zacks)
10:11AM	AbbVie Stock on the Move: What Sparked the 6% Jump in the Past Week? (Zacks)
09:56AM	Eli Lilly: Beyond Weight Loss (Motley Fool)
09:03AM	Zacks Value Trader Highlights: Pfizer, Merck, AbbVie, Eli Lilly and Novo Nordisk (Zacks)
07:35AM	Trogenix lands $95m Series A, backed by Eli Lilly, for brain cancer therapy (Pharmaceutical Technology)
06:30AM	Eli Lilly to invest over $1 billion in India in global expansion (Reuters Videos)
Oct-04-25 05:01PM	Jim Cramer Highlights Eli Lilly's Drug Potential Beyond Diabetes and Obesity (Insider Monkey)
02:30AM	Novo Nordisk Is Ready for Another Round of the Weight-Loss-Drug Wars (Barrons.com)
Oct-03-25 05:45PM	Eli Lilly (LLY) Laps the Stock Market: Here's Why (Zacks)
04:55PM	5 Large Cap Drug Stocks: Values or Traps? (Zacks)
11:48AM	Palantir, AI bubble comments, pharma stocks: Trending Tickers (Yahoo Finance Video)
10:47AM	Why Shares of Eli Lilly Soared This Week (Motley Fool)
10:06AM	MRK Stock Up Nearly 14% So Far This Week: What's Driving It? (Zacks)
09:59AM	Is PFE Stock a Buy After 14% Rise Post Drug Pricing Deal With Trump? (Zacks)
09:38AM	Analyst Explains Why Eli Lilly (LLY) GLP-1 Advantage is Decreasing (Insider Monkey)
09:28AM	Pharma Stocks Eye Best Week in 16 Years as Trump Overhang Eases (Bloomberg)
06:27AM	Eli Lilly and Company (LLY) Gets Upgraded to a Buy by CFRA (Insider Monkey)
Oct-02-25 10:11PM	Pfizers Drug-Price Deal With Trump Followed Months of Deadlock (Bloomberg)
12:52PM	Buy Novo Nordisk Stock as Health Names Return to Favor, Analyst Says (Barrons.com)
05:27AM	3 Blue Chip Stocks That Have Soared 380% (and Higher) Over the Past 5 Years (Motley Fool)
02:08AM	Eli Lilly (LLY) Rated Outperform With Strong GLP-1 Prospects (Insider Monkey)
Oct-01-25 07:33PM	Analyst Report: Eli Lilly and Company (Morningstar Research) +8.18%
04:55PM	Drug Stock Rally Helps Push Dow and S&P 500 to Records (The Wall Street Journal)
04:40PM	Stocks to Watch Wednesday: Meta, Netflix, Nike, Lithium Americas (The Wall Street Journal)
04:36PM	Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff (Investor's Business Daily)
04:01PM	Why Is Eli Lilly (LLY) Stock Rocketing Higher Today (StockStory)
03:19PM	Trump Triggered a Rally in Drug Stocks. Why It Might Not Last. (Barrons.com)
02:48PM	Pharma stocks are powering the Nasdaq Composite and S&P 500 higher in afternoon trading (MarketWatch)
01:53PM	Another Surging Pharma Stock to Watch Right Now (Schaeffer's Research)
01:46PM	Eli Lilly and Company (LLY) Expands Global Reach with Orforglipron Launch Plans in India (Insider Monkey)
12:35PM	Top Stock Movers Now: Nike, Eli Lilly, Corteva, AES, and More (Investopedia)
12:17PM	Reddit sinks on ChatGPT data, Pfizer deal boosts pharma stocks (Yahoo Finance Video)
11:44AM	Pfizer Stock, Other Drugmakers Rally Again (The Wall Street Journal)
11:03AM	Q: Will TrumpRx and 'Most Favored Nation' Deals Save Americans Money? (The Wall Street Journal)
10:01AM	What TrumpRx Means For Controversial Plan To Lower U.S. Drug Prices (Investor's Business Daily)
09:22AM	Stock Market News for Oct 1, 2025 (Zacks)
08:03AM	Big Pharma's big boost: Market Movers (Yahoo Finance Video)
Sep-30-25 05:15PM	Eli Lilly and Company (LLY) Halts Experimental Study of Muscle-Sparing Obesity Drug (Insider Monkey) +5.02%
05:14PM	Pfizer Stock Surges After Company Makes a Deal With President Trump (The Wall Street Journal)
04:48PM	Eli Lilly and Company (LLY) Opens a New Lilly Gateway Labs Innovation Hub in San Diego (Insider Monkey)
04:47PM	Pfizer Stock Soars on Trumps New Drug Pricing Plan. Heres Why. (Barrons.com)
04:41PM	Stocks Settle Higher as Drug Makers and Chip Stocks Rally (Barchart)
04:38PM	Stocks Post Late Rally After Trump Strikes Deal With Pfizer (The Wall Street Journal)
04:05PM	Why Are Eli Lilly (LLY) Shares Soaring Today (StockStory)
03:59PM	Eli Lilly in negotiations with Trump administration for the next pharma deal (CNBC TV)
12:48PM	Trump's Plan To Lower U.S. Drug Prices Faces Big Test (Investor's Business Daily)
11:02AM	Metsera Posts Promising Weight-Loss Drug Results. It Could Be a Win for Pfizer. (Barrons.com)
10:45AM	Can NVO Maintain Obesity Leadership With Next-Generation Candidates? (Zacks)
09:30AM	Is Lilly (LLY) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
07:50AM	Metsera strengthens case for Pfizer buyout with latest study data (BioPharma Dive)
07:19AM	Citigroup forecasts Big Tech's AI spending to cross $2.8 trillion by 2029 (Reuters)
04:15AM	These 2 Top Dividend Stocks Are Finally Rebounding, and There Might Be More Upside Ahead (Motley Fool)
01:52AM	Big Pharmas retreat: Is NHS pricing behind investor pullbacks? (Euronews)
Sep-29-25 09:06PM	3 Growth Stocks to Invest $1,000 Right Now (Motley Fool)
12:33PM	Weight Loss Wars: Is Novo Nordisks Dominance Safe Against Eli Lilly? (Barchart)
12:33PM	How Eli Lilly (LLY) Balances Dividend Payouts With Long-Term Innovation (Insider Monkey)
10:23AM	Trials to watch: Three major catalysts in Alzheimers disease (Clinical Trials Arena)
10:13AM	Novo Nordisk Stock Is Downgraded. There's a 'Tough Path Ahead.' (Barrons.com)
10:04AM	Can RIGL's Oncology Portfolio Create Long-Term Value Beyond Tavalisse? (Zacks)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LILLY ENDOWMENT INC	10% Owner	Oct 09 '25	Sale	852.49	10,602	9,038,055	94,536,978	Oct 10 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 10 '25	Proposed Sale	855.35	305,000	260,881,750		Oct 10 02:57 PM
LILLY ENDOWMENT INC	10% Owner	Oct 08 '25	Sale	850.27	101,420	86,234,874	94,547,580	Oct 09 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 07 '25	Sale	848.01	26,795	22,722,401	94,649,000	Oct 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Sale	850.22	161,183	137,041,657	94,675,795	Oct 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 03 '25	Sale	837.93	192,404	161,220,401	94,836,978	Oct 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Proposed Sale	839.87	300,000	251,961,000		Oct 06 03:35 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Sale	821.55	112,596	92,503,361	95,029,382	Oct 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	821.47	215,822	177,290,448	95,141,978	Oct 02 04:56 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	794.15	135,193	107,363,016	95,357,800	Oct 02 04:55 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Proposed Sale	825.42	305,000	251,753,100		Oct 02 03:20 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Proposed Sale	763.00	295,000	225,085,000		Oct 01 04:08 PM
LILLY ENDOWMENT INC	10% Owner	Sep 30 '25	Sale	763.39	113,694	86,793,274	95,492,993	Oct 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 19 '25	Sale	763.10	23,665	18,058,643	95,606,687	Sep 22 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 18 '25	Sale	764.65	106,626	81,531,959	95,630,352	Sep 19 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 18 '25	Proposed Sale	760.13	300,000	228,039,000		Sep 18 03:04 PM
DONALD ZAKROWSKI	Officer	Aug 28 '25	Proposed Sale	734.17	2,000	1,468,340		Aug 28 04:19 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 28 '25	Sale	734.93	1,000	734,930	3,840	Aug 28 04:14 PM
Montarce Lucas	EVP & CFO	Aug 15 '25	Buy	691.79	715	494,627	14,685	Aug 15 04:13 PM
Alvarez Ralph	Director	Aug 13 '25	Buy	660.25	758	500,473	758	Aug 14 04:12 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Aug 13 '25	Buy	647.36	1,000	647,360	20,562	Aug 13 04:15 PM
Ricks David A	President, Chair, and CEO	Aug 12 '25	Buy	644.77	1,632	1,052,263	546,601	Aug 12 04:23 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Aug 12 '25	Buy	634.40	1,000	634,405	137,660	Aug 12 04:20 PM
Sulzberger Gabrielle	Director	Aug 12 '25	Buy	641.18	117	75,018	2,703	Aug 12 04:19 PM
Fyrwald J Erik	Director	Aug 12 '25	Buy	642.33	1,565	1,005,242	74,578	Aug 12 04:17 PM
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Aug 11 '25	Sale	627.01	1,250	783,762	26,260	Aug 12 04:16 PM
JACKSON JAMERE	Director	Aug 08 '25	Buy	639.56	200	127,913	9,402	Aug 08 04:20 PM
Seymour Melissa	EVP, Global Quality	Aug 01 '25	Option Exercise	0.00	952	0	952	Aug 04 04:16 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Sale	805.07	280,000	225,419,259	95,736,978	Jul 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Proposed Sale	798.89	280,000	223,689,200		Jul 24 03:01 PM
Zakrowski Donald A	SVP, Finance, & CAO	May 27 '25	Sale	716.41	1,000	716,410	4,840	May 27 04:13 PM
Yuffa Ilya	EVP & President, LLY Int'l	May 14 '25	Sale	749.24	1,250	936,550	27,510	May 15 04:17 PM
Yuffa Ilya	Officer	May 14 '25	Proposed Sale	749.24	2,500	1,873,100		May 14 12:25 PM
DONALD ZAKROWSKI	Officer	Mar 13 '25	Proposed Sale	821.86	2,000	1,643,720		Mar 13 04:57 PM
Zakrowski Donald A	SVP, Finance, & CAO	Mar 13 '25	Sale	818.24	1,000	818,240	5,840	Mar 13 04:17 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Sale	928.76	220,000	204,326,151	96,016,978	Mar 04 04:00 PM
Dozier Eric	EVP, Chief People Officer	Mar 01 '25	Option Exercise	0.00	2,403	0	10,905	Mar 03 04:53 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Mar 01 '25	Option Exercise	0.00	2,837	0	41,009	Mar 03 04:51 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Proposed Sale	920.63	220,000	202,538,600		Mar 03 03:34 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Sale	903.07	225,000	203,190,794	96,236,978	Feb 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 24 '25	Sale	883.97	60,432	53,419,955	96,461,978	Feb 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Proposed Sale	881.40	225,000	198,315,000		Feb 25 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 21 '25	Sale	882.70	99,452	87,786,505	96,522,410	Feb 24 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 20 '25	Sale	877.99	14,685	12,893,353	96,621,862	Feb 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 19 '25	Sale	878.45	9,985	8,771,285	96,636,547	Feb 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Sale	879.52	35,446	31,175,396	96,646,532	Feb 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Proposed Sale	872.97	220,000	192,053,400		Feb 13 03:43 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 10 '25	Sale	863.21	5,000	4,316,065	117,888	Feb 12 04:15 PM
Skovronsky Daniel	Officer	Feb 10 '25	Proposed Sale	863.19	5,000	4,315,954		Feb 10 11:44 AM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Sale	874.13	210,000	183,567,262	96,681,978	Feb 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Proposed Sale	842.18	210,000	176,857,800		Feb 06 04:04 PM
Yuffa Ilya	EVP & President, LLY Int'l	Feb 01 '25	Option Exercise	0.00	3,269	0	23,071	Feb 04 04:28 PM
White Anne E.	EVP & Pres, Lilly Neuroscience	Feb 01 '25	Option Exercise	0.00	3,269	0	68,838	Feb 04 04:27 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Feb 01 '25	Option Exercise	0.00	3,023	0	14,868	Feb 04 04:26 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 01 '25	Option Exercise	0.00	8,989	0	126,892	Feb 04 04:25 PM
Ricks David A	President, Chair, and CEO	Feb 01 '25	Option Exercise	0.00	26,561	0	496,385	Feb 04 04:24 PM
Rau Diogo	EVP & CIDO	Feb 01 '25	Option Exercise	0.00	3,269	0	14,370	Feb 04 04:23 PM
Jonsson Patrik	EVP&Pres, CardMetHlth, LLY USA	Feb 01 '25	Option Exercise	0.00	3,433	0	48,016	Feb 04 04:23 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Feb 01 '25	Option Exercise	0.00	2,861	0	33,479	Feb 04 04:21 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '25	Option Exercise	0.00	4,904	0	20,683	Feb 04 04:19 PM
Zakrowski Donald A	Officer	Nov 08 '24	Proposed Sale	803.38	900	723,042		Nov 08 04:54 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 08 '24	Sale	803.38	900	723,042	5,480	Nov 08 04:18 PM
Montarce Lucas	EVP & CFO	Nov 01 '24	Option Exercise	0.00	1,074	0	11,541	Nov 05 04:15 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Nov 01 '24	Option Exercise	0.00	1,687	0	31,369	Nov 05 04:14 PM
Dozier Eric	EVP, HR & Diversity	Nov 01 '24	Option Exercise	0.00	1,534	0	8,724	Nov 05 04:13 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LLY

Lilly(Eli) & Co

Upgrade your FINVIZ experience